Operating Lease, Weighted Average Discount Rate, Percent of Viridian Therapeutics, Inc.\DE from 31 Dec 2024 to 31 Dec 2025

Taxonomy & unit
us-gaap: pure
Description
Weighted average discount rate for operating lease calculated at point in time.
Summary
Viridian Therapeutics, Inc.\DE quarterly Operating Lease, Weighted Average Discount Rate, Percent in pure history and change rate from 31 Dec 2024 to 31 Dec 2025.
  • Viridian Therapeutics, Inc.\DE Operating Lease, Weighted Average Discount Rate, Percent for the quarter ending 31 Dec 2025 was 0.092, a 1.1% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Weighted Average Discount Rate, Percent, Quarterly (pure)
Operating Lease, Weighted Average Discount Rate, Percent, YoY Quarterly Change (%)

Viridian Therapeutics, Inc.\DE Quarterly Operating Lease, Weighted Average Discount Rate, Percent (pure)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 0.092 -0.001 -1.1% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 0.092 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 0.093 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 0.093 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 0.093 31 Dec 2024 10-K 26 Feb 2026 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.